The effect of remimazolam and propofol on visual evoked potential

Not Applicable

• Conditions: Brain neoplasm; Brain tumor; D001932

• Registration Number: JPRN-jRCT1011230057
• Lead Sponsor: Chaki Tomohiro

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-01-22
• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients who undergo neurosurgery using VEP monitoring
Patients whose age more than 20 yrs

Exclusion Criteria

Patients who VEP monitoring can not be performed appropriately

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Amplitude of visual evoked potential at Oz between N1-P1

Secondary Outcome Measures

Name	Time	Method
Amplitude of visual evoked potential at Oz between P1-N2<br>Latency of visual evoked potential at N1, P1 and N2<br>Hemodynamic state including blood pressure and heart rate<br>Depth of sedation evaluated by bistral index value